Literature DB >> 23394816

A unique presentation of Epstein-Barr virus-associated Castleman's disease.

Heather Gomes1, Phillip Huyett, Nora Laver, Richard O Wein.   

Abstract

Castleman's disease (CD) is a rare, benign lymphoproliferative disorder. The association of human herpes virus 8 (HHV8) and human immunodeficiency virus infections with CD is well established however the role of Epstein-Barr Virus in CD is less well understood. We present a unique case of Castleman's disease in a patient with concomitant EBV infection, which mimicked the clinical presentation of nasopharyngeal carcinoma (NPC) versus lymphoma. After a delayed diagnosis, the patient underwent a left superficial parotidectomy and neck dissection and has had no recurrence of disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23394816     DOI: 10.1016/j.amjoto.2012.12.003

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  4 in total

1.  Resection is an effective treatment for recurrent follicular dendritic cell sarcoma from retroperitoneum: unusual presentation of a rare tumor.

Authors:  Jie Hu; Ling-Li Chen; Bo-Wen Ding; Da-Yong Jin; Xue-Feng Xu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

Review 3.  Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection?

Authors:  Solène Grayo
Journal:  Viruses       Date:  2021-04-13       Impact factor: 5.048

4.  Castleman's Disease Presenting as a Parotid Mass in the Pediatric Population: A Report of 2 Cases.

Authors:  Sean W Delaney; Shengmei Zhou; Dennis Maceri
Journal:  Case Rep Otolaryngol       Date:  2015-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.